Drug Type in vivo CAR-T therapy |
Synonyms- |
Target |
Action modulators |
Mechanism CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | United States | 12 May 2026 |





